Nutex Health Inc. (NUTX): Nasdaq/NYSE listing notice — Nutex Health Q3 prelim: cash collections up 259% YoY, patient volume +11.1%; Nasdaq extension granted

Nutex Health Inc.

2025-Q3 EPS reported $8.87 revenue$723,578,000

Preliminary Q3 2025 patient volume of 46,293 visits, up 11.1% vs Q3 2024.
Cash collections for Q3 2025 surged 258.8% to $235M, driven by revenue cycle improvements.
YTD 2025 cash collections $546M, up 176.9% vs YTD 2024; patient volume +14% to 140,135.
Nasdaq extended deadline to Dec 12, 2025, for filing delinquent Q2 2025 10-Q.
Company warns preliminary metrics are unaudited and subject to change upon final review.

item 2.02 item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Nutex Health Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

August 20, 2025, the Company received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that due to the Company’s failure to timely file its Quarterly Report on Form 10-Q for the period ended June 30, 2025 (the “June 30, 2025 Form 10-Q”) with the Securities and Exchange Commission (the “SEC”), the Company is not in compliance with Nasdaq’s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires the timely filing of all required periodic reports with the SEC. On October 15

View on SEC.gov

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Nutex Health Inc. received a nasdaq extension granted notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: extension granted
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

October 16, 2025. In the event the Company is not able to file the June 30, 2025 Form 10-Q with the SEC on or before December 12, 2025, the staff of Nasdaq will issue a delisting notice, which the Company may appeal to a Nasdaq Hearings Panel.

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Nutex Health Inc. filing history →

Source: SEC EDGAR

accession 0001479681-25-000085

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.